Literature DB >> 32823438

Combined infection of ocular tuberculoma and cytomegalovirus retinitis in the same eye of a patient with human immunodeficiency virus.

Sridharan Sudharshan1, Rajesh B Babu2, Nivedita Nair1, Jyotirmay Biswas1.   

Abstract

Entities:  

Keywords:  Choroidal tuberculoma; Cytomegalovirus retinitis; HIV; Highly active antiretroviral therapy; Ocular TB

Mesh:

Year:  2020        PMID: 32823438      PMCID: PMC7690518          DOI: 10.4103/ijo.IJO_1321_20

Source DB:  PubMed          Journal:  Indian J Ophthalmol        ISSN: 0301-4738            Impact factor:   1.848


× No keyword cloud information.
  6 in total

1.  Aspergillus fumigatus, Pneumocystis jiroveci, Klebsiella pneumoniae & Mycoplasma fermentans co-infection in a HIV infected patient with respiratory conditions from Southern India.

Authors:  E M Shankar; Nagalingeswaran Kumarasamy; Ramachandran Rajan; P Balakrishnan; Suniti Solomon; Bella Devaleenol; U A Rao
Journal:  Indian J Med Res       Date:  2006-02       Impact factor: 2.375

2.  Challenging treatment of bilateral multiple infection panuveitis in HIV/AIDS patients.

Authors:  Widya Artini; Soedarman Sjamsoe; Made Susiyanti
Journal:  Int J Ophthalmol       Date:  2018-06-18       Impact factor: 1.779

3.  Longitudinal study of the ocular complications of AIDS: 2. Ocular examination results at enrollment.

Authors:  Douglas A Jabs; Mark L Van Natta; Janet T Holbrook; John H Kempen; Curtis L Meinert; Matthew D Davis
Journal:  Ophthalmology       Date:  2007-01-08       Impact factor: 12.079

4.  Risk factors for mortality in patients with AIDS in the era of highly active antiretroviral therapy.

Authors:  Douglas A Jabs; Janet T Holbrook; Mark L Van Natta; Rebecca Clark; Mark A Jacobson; John H Kempen; Robert L Murphy
Journal:  Ophthalmology       Date:  2005-05       Impact factor: 12.079

Review 5.  AIDS and ophthalmology: the first quarter century.

Authors:  Gary N Holland
Journal:  Am J Ophthalmol       Date:  2008-03       Impact factor: 5.258

Review 6.  The Role of Fluoroquinolones in the Treatment of Tuberculosis in 2019.

Authors:  A D Pranger; T S van der Werf; J G W Kosterink; J W C Alffenaar
Journal:  Drugs       Date:  2019-02       Impact factor: 9.546

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.